New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether some stage III melanoma patients are likely to suffer recurrences of cancerous tumors. ...[TheTopNews] Read More.
UPI News – Health News | Health & WellnessTue, April 15, 2025